Person · CIK 2150104

Roberto Wandenkolk Vieira

President at Corcept Therapeutics

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$7.5M
Noticed on Form 144$8.3M
Bought on Form 4$0
Companies1

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

CompanySecurityHeldShares or unitsAs of
Corcept Therapeutics CORTCommon StockDirectly3,946Oct 2, 2026 · Filing · EDGAR
Corcept Therapeutics CORTStock option (right to buy)
exercise $21.63, expires Feb 1, 2034, into Common Stock
Directly133,334Oct 2, 2026 · Filing · EDGAR

Sold and noticed by quarter

Roberto Wandenkolk Vieira: dollars sold on Form 4 and noticed on Form 144 per quarter, Q1 2025 to Q4 2026$8.3M$0Q1 2025: $0 noticed on Form 144Q1 2025: $0 sold on Form 4Q2 2025: $0 noticed on Form 144Q2 2025: $0 sold on Form 4Q3 2025: $0 noticed on Form 144Q3 2025: $0 sold on Form 4Q4 2025: $0 noticed on Form 144Q4 2025: $0 sold on Form 4Q1 2026: $0 noticed on Form 144Q1 2026: $0 sold on Form 4Q2 2026: $0 noticed on Form 144Q2 2026: $0 sold on Form 4Q3 2026: $8.3M noticed on Form 144Q3 2026: $6.5M sold on Form 4Q4 2026: $0 noticed on Form 144Q4 2026: $967K sold on Form 4Q1 2025Q3 2025Q1 2026Q3 2026

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table
QuarterSold (Form 4)Noticed (Form 144)
Q4 2026$967K—
Q3 2026$6.5M$8.3M

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice dateNoticedPlanned saleOutcomeLinks
Corcept Therapeutics CORT · Stifel Nicolaus & Company · 10b5-1 plan adopted Jun 17, 2026 · 1 notice
Sep 2, 202675,295 · ~$8.3MSep 2, 2026Partly sold Sold 66,962 in 11 sales, Sep 2 to Oct 2 · $7.5M likely match Form 4 (1) · Form 4 (2) · Form 4 (3)Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Corcept Therapeutics CORT President, Oncology · filings 2026 to 2026 · sold $7.5M · $8.3M noticed on Form 144

DateTransactionSharesPriceValueHeld afterSource
Oct 2, 2026Option or RSU exercised or converted+8,333$21.63$180K12,279 directFiling · EDGAR
Oct 2, 2026Sale under a 10b5-1 plan−1,100$114.52$126K11,179 directFiling · EDGAR
Oct 2, 2026Sale under a 10b5-1 plan−2,086$115.73$241K9,093 directFiling · EDGAR
Oct 2, 2026Sale under a 10b5-1 plan−5,147$116.59$600K3,946 directFiling · EDGAR
Oct 2, 2026Option or RSU exercised or converted
Stock option (right to buy)
−8,333133,334 directFiling · EDGAR
Sep 16, 2026Sale under a 10b5-1 plan−296$100.82$30K3,946 directFiling · EDGAR
Sep 2, 2026Shares withheld for tax or exercise price−102$113.38$12K4,242 directFiling · EDGAR
Sep 2, 2026Option or RSU exercised or converted+58,333$21.63$1.3M62,575 directFiling · EDGAR
Sep 2, 2026Sale under a 10b5-1 plan−23,600$109.35$2.6M38,975 directFiling · EDGAR
Sep 2, 2026Sale under a 10b5-1 plan−23,770$110.70$2.6M15,205 directFiling · EDGAR
Sep 2, 2026Sale under a 10b5-1 plan−1,537$111.37$171K13,668 directFiling · EDGAR
Sep 2, 2026Sale under a 10b5-1 plan−974$112.40$109K12,694 directFiling · EDGAR
Sep 2, 2026Sale under a 10b5-1 plan−1,606$113.72$183K11,088 directFiling · EDGAR
Sep 2, 2026Sale under a 10b5-1 plan−5,621$114.58$644K5,467 directFiling · EDGAR
Sep 2, 2026Sale under a 10b5-1 plan−1,225$115.44$141K4,242 directFiling · EDGAR
Sep 2, 2026Option or RSU exercised or converted
Stock option (right to buy)
−58,333141,667 directFiling · EDGAR
Sep 1, 2026Grant or award from the company+138$113.38$16K4,206 directFiling · EDGAR
Sep 1, 2026Grant or award from the company+1384,344 directFiling · EDGAR
All 5 Forms 3, 4, 5 and 144
FiledFormCompanyLinks
Oct 5, 2026Form 4Corcept Therapeutics CORTFiling · EDGAR
Sep 18, 2026Form 4Corcept Therapeutics CORTFiling · EDGAR
Sep 3, 2026Form 4Corcept Therapeutics CORTFiling · EDGAR
Sep 3, 2026Form 3Corcept Therapeutics CORTFiling · EDGAR
Sep 2, 2026Form 144Corcept Therapeutics CORTFiling · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched . The filing on SEC.gov is the record.